Company: IOBT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0000950170-25-058699
Chunk: 40

Company: IO Biotech, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 40
---
 over 6,173,439 shares held by Vivo Opportunity Fund Holdings, L.P., of which Vivo Opportunity Funds, L.P. is the general partner and currently exercisable warrants to acquire 3,157,894 shares of common stock at an exercise price of $2.47. The managing members of Vivo Opportunity, LLC, Gaurav Aggarwal, Hongbo Lu, Kevin Dai, Frank Kung and Michael Chang, may be deemed to share voting and investment power with respect to such shares. None of such managing members have individual voting or investment power with respect to these shares and each of whom disclaims beneficial ownership of such shares. The principal business address of Vivo Capital IX, LLC is 192 Lytton Avenue, Palo Alto, CA 94301.

Based solely on a Schedule 13D/A filed on September 17, 2024 by Novo Holdings A/S reporting sole voting and dispositive power over 3,354,449 shares of common stock and currently exercisable warrants to acquire 2,469,135 shares of common stock at an exercise price of $2.47. The principal business address for Novo Holdings A/S is Tuborg Havnevej 19, 2900 Hellerup, Denmark.

Based solely on a Schedule 13G/A filed on February 13, 2025 by HBM Healthcare Investments (Cayman) Ltd. reporting sole voting and dispositive power over 3,944,492 shares of common stock and currently exercisable warrants to acquire 1,578,947 shares of common stock at an exercise price of $2.47. Voting and investment power over the shares held by HBM Healthcare Investments (Cayman) Ltd. is exercised by its board, consisting of Jean-Marc LeSieer, Richard H. Coles, Sophia Harris, Dr. Andreas Wicki, Mark Kronenfeld, M.D. and Richard Paul Woodhouse, none of whom has individual voting or investment power with respect to the shares. The principal business address for HBM Healthcare Investments (Cayman) Ltd. is Governor’s Square, 23 Lime Tree Bay Avenue, PO Box 30852, Grand Cayman, Cayman Islands.

Consists of (i) 49,891 shares of common stock held by Dr. Zocca, (ii) 26,580 shares of common stock held by Zocca Consulting ApS and (iii) 1,426,280 shares of common stock issuable upon exercise of options and